Background: Isolation and characterization of tumourigenic colon cancer initiating cells may help to develop novel diagnostic and therapeutic procedures. Methods: We characterized a panel of fourteen human colon carcinoma cell lines and their corresponding xenografts for the surface expression of potential stem cell markers CD133, CD24, CD44, CDCP1 and CXCR4. In five cell lines and nine xenografts, mRNA expression of these markers was determined. Tumour growth behaviour of CD133+, CD133- and unsorted SW620 cells was evaluated in vivo. Results: All five putative stem cell markers showed distinct expression patterns in the tumours examined. Two patient-derived cell lines highly expressed CD133 (> 85 % of positive cells) and three other cel...
AIM: To verify that CD markers are available for detecting cancer stem cell populations and to evalu...
[[abstract]]Background: Positive expression of CD44 and CD133 and high expression levels of an epith...
[[abstract]]Background: Positive expression of CD44 and CD133 and high expression levels of an epith...
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of tr...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
First developed for hematologic disorders, the concept of cancer stem cells (CSCs) was expanded to s...
First developed for hematologic disorders, the concept of cancer stem cells (CSCs) was expanded to s...
Abstract: Background. Mounting evidence suggests that most tumors consist of a heterogeneous populat...
Although relatively good therapeutic results are achieved in non-advanced cancer, the prognosis of t...
We previously reported that CD133, as a putative cancer stem cell marker, plays an important role in...
Although relatively good therapeutic results are achieved in non-advanced cancer, the prognosis of t...
Copyright © 2014 Pavel Pitule et al. This is an open access article distributed under the Creative C...
Several surface markers have been proposed for the identification and characterization of colorectal...
Several surface markers have been proposed for the identification and characterization of colorectal...
AIM: To verify that CD markers are available for detecting cancer stem cell populations and to evalu...
[[abstract]]Background: Positive expression of CD44 and CD133 and high expression levels of an epith...
[[abstract]]Background: Positive expression of CD44 and CD133 and high expression levels of an epith...
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of tr...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
First developed for hematologic disorders, the concept of cancer stem cells (CSCs) was expanded to s...
First developed for hematologic disorders, the concept of cancer stem cells (CSCs) was expanded to s...
Abstract: Background. Mounting evidence suggests that most tumors consist of a heterogeneous populat...
Although relatively good therapeutic results are achieved in non-advanced cancer, the prognosis of t...
We previously reported that CD133, as a putative cancer stem cell marker, plays an important role in...
Although relatively good therapeutic results are achieved in non-advanced cancer, the prognosis of t...
Copyright © 2014 Pavel Pitule et al. This is an open access article distributed under the Creative C...
Several surface markers have been proposed for the identification and characterization of colorectal...
Several surface markers have been proposed for the identification and characterization of colorectal...
AIM: To verify that CD markers are available for detecting cancer stem cell populations and to evalu...
[[abstract]]Background: Positive expression of CD44 and CD133 and high expression levels of an epith...
[[abstract]]Background: Positive expression of CD44 and CD133 and high expression levels of an epith...